OncoCyte Files Patents for 190 Newly Identified Novel Lung Cancer Biomarkers
ALAMEDA, Calif., April 02, 2018 (GLOBE NEWSWIRE) — OncoCyte Corporation (NYSE American:OCX), a developer of novel, non-invasive liquid biopsy diagnostic tests for the early detection of cancer, strengthened its intellectual property portfolio as it filed global patent applications for 190 newly …